Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
1,309,286
-
Share change
-
-115,021
-
Total reported value
-
$1,297,302
-
Price per share
-
$0.99
-
Number of holders
-
41
-
Value change
-
-$118,709
-
Number of buys
-
15
-
Number of sells
-
13
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q2 2024
As of 30 Jun 2024,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,309,286 shares.
The largest 10 holders included
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, SEEDS INVESTOR LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, GOLDMAN SACHS GROUP INC, COMMONWEALTH EQUITY SERVICES, LLC, Royal Bank of Canada, CIBC WORLD MARKET INC., GEODE CAPITAL MANAGEMENT, LLC, and Long Focus Capital Management, LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.